NYSE:HAE

Haemonetics Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy HAE

*Your capital is at risk

$65.88

-0.490 (-0.738%)

At Close: Jun 03, 2026

Haemonetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 77.81. In total, the insiders bought 866.72K and sold 110.4K HAE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	77.81
● Buy	866.72K shares
● Sell	110.4K shares
72% Buy Activity Weak Negative Correlation
Buy Signal Medium Confidence May 15, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 77.81. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 30, 2025 Buy	Common Stock A-Award	Darecca James EVP, Chief Financial Officer	C-Suite Officer	12 221 Value: $827.5K
May 30, 2025 Sell	Common Stock F-InKind	Miller Laurie A. SVP, Human Resources	Officer	2 283 Value: $158.4K
May 30, 2025 Buy	Common Stock A-Award	Miller Laurie A. SVP, Human Resources	Officer	7 777 Value: $526.6K
May 30, 2025 Sell	Common Stock F-InKind	Simon, Christopher President & CEO	CEO / President	26 234 Value: $1.82M
May 30, 2025 Buy	Common Stock A-Award	Simon, Christopher President & CEO	CEO / President	66 666 Value: $4.51M
May 16, 2025 Buy	Common Stock A-Award	Basil Michelle L EVP And General Counsel	Officer	6 755 Value: $474.9K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Basil Michelle L EVP And General Counsel	Officer	14 626 Value: $1.03M
May 16, 2025 Buy	Common Stock A-Award	Galvin Roy EVP, Chief Commercial Officer	Officer	5 689 Value: $400.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Galvin Roy EVP, Chief Commercial Officer	Officer	12 317 Value: $866.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Galvin Roy EVP, Chief Commercial Officer	Officer	12 317 Value: $866.0K
May 16, 2025 Buy	Common Stock A-Award	Galvin Roy EVP, Chief Commercial Officer	Officer	5 689 Value: $400.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Basil Michelle L EVP And General Counsel	Officer	14 626 Value: $1.03M
May 16, 2025 Buy	Common Stock A-Award	Basil Michelle L EVP And General Counsel	Officer	6 755 Value: $474.9K
May 16, 2025 Buy	Common Stock A-Award	Maunsell Farris Maryanne Vp, Chief Accounting Officer	Officer	800 Value: $56.2K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Maunsell Farris Maryanne Vp, Chief Accounting Officer	Officer	1 732 Value: $121.8K
May 16, 2025 Buy	Common Stock A-Award	Miller Laurie A. SVP, Human Resources	Officer	3 200 Value: $225.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Miller Laurie A. SVP, Human Resources	Officer	6 928 Value: $487.1K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Chan Frank EVP, Chief Operating Officer	C-Suite Officer	12 317 Value: $866.0K
May 16, 2025 Buy	Common Stock A-Award	Chan Frank EVP, Chief Operating Officer	C-Suite Officer	5 689 Value: $400.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Galvin Roy President, Global Plasma & Bc	CEO / President	14 626 Value: $1.03M
May 16, 2025 Buy	Common Stock A-Award	Galvin Roy President, Global Plasma & Bc	CEO / President	6 755 Value: $474.9K
May 16, 2025 Buy	Common Stock A-Award	Basil Michelle L EVP And General Counsel	Officer	5 689 Value: $400.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Basil Michelle L EVP And General Counsel	Officer	12 317 Value: $866.0K
May 16, 2025 Buy	Common Stock A-Award	Darecca James EVP, Chief Financial Officer	C-Suite Officer	7 111 Value: $500.0K
May 16, 2025 Buy	Non-qualified Stock Option (Right to Buy) A-Award	Darecca James EVP, Chief Financial Officer	C-Suite Officer	15 396 Value: $1.08M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HAEMONETICS CORPORATION

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their d...

Read Full Profile Here